Cleared Special

K030124 - OLYMPUS FERRITIN REAGENT

K030124 is the FDA 510(k) clearance for OLYMPUS FERRITIN REAGENT by Olympus America, Inc.. It is a Class 2 Immunology device (product code DBF) cleared through the Special 510(k) pathway after a 23-day FDA review.

K030124 · Olympus America, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2003
Decision
23d
Days
Class 2
Risk

K030124 is an FDA 510(k) clearance for the OLYMPUS FERRITIN REAGENT. Classified as Ferritin, Antigen, Antiserum, Control (product code DBF), Class II - Special Controls.

Submitted by Olympus America, Inc. (Irving, US). The FDA issued a Cleared decision on February 6, 2003 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5340 - the FDA immunology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Olympus America, Inc. devices

Submission Details

510(k) Number K030124 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 14, 2003
Decision Date February 06, 2003
Days to Decision 23 days
Submission Type Special
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 104d · This submission: 23d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DBF Ferritin, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DBF Ferritin, Antigen, Antiserum, Control

All 63
Devices cleared under the same product code (DBF) and FDA review panel - the closest regulatory comparables to K030124.
K-ASSAY FERRITIN (2) & FERRITIN CALIBRATOR SET
K050944 · Kamiya Biomedical Co. · Dec 2005
QUANTEX FERRITIN
K040879 · Instrumentation Laboratory CO · May 2004
FERRITIN GENERATION 2
K031650 · Roche Diagnostics Corp. · Jul 2003
K-ASSAY FERRITIN, K-ASSAY FERRITIN CALIBRATOR SET
K014293 · Kamiya Biomedical Co. · Feb 2002
RANDOX FERRITIN
K000662 · Randox Laboratories, Ltd. · Apr 2000
N LATEX FERRITIN
K993273 · Dade Behring, Inc. · Nov 1999